Teyi Pharmaceutical (China) Today
| 002728 Stock | 8.10 0.05 0.61% |
PerformanceVery Weak
| Odds Of DistressVery Small
|
Teyi Pharmaceutical is trading at 8.10 as of the 26th of February 2025, a 0.61 percent decrease since the beginning of the trading day. The stock's open price was 8.15. Teyi Pharmaceutical has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 4th of November 2023 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Teyi Pharmaceutical is entity of China. It is traded as Stock on SHE exchange. The company has 510.79 M outstanding shares. More on Teyi Pharmaceutical Group
Moving together with Teyi Stock
Moving against Teyi Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Teyi Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Teyi Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Teyi Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Teyi Pharmaceutical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Teyi Pharmaceutical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsTeyi Pharmaceutical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Teyi Pharmaceutical's financial leverage. It provides some insight into what part of Teyi Pharmaceutical's total assets is financed by creditors.
| |||||
Teyi Pharmaceutical Group (002728) is traded on Shenzhen Stock Exchange in China and employs 4 people. Teyi Pharmaceutical is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.12 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teyi Pharmaceutical's market, we take the total number of its shares issued and multiply it by Teyi Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Teyi Pharmaceutical operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 510.79 M outstanding shares.
Teyi Pharmaceutical generates positive cash flow from operations, but has no cash available
Check Teyi Pharmaceutical Probability Of Bankruptcy
Ownership AllocationTeyi Pharmaceutical shows a total of 510.79 Million outstanding shares. Teyi Pharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Teyi Ownership Details
Teyi Pharmaceutical Risk Profiles
Although Teyi Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Teyi Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.86 | |||
| Standard Deviation | 2.51 | |||
| Variance | 6.32 | |||
| Risk Adjusted Performance | (0.02) |
Teyi Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Teyi Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Teyi Pharmaceutical Corporate Executives
Elected by the shareholders, the Teyi Pharmaceutical's board of directors comprises two types of representatives: Teyi Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Teyi. The board's role is to monitor Teyi Pharmaceutical's management team and ensure that shareholders' interests are well served. Teyi Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Teyi Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiliang Chen | Deputy CFO | Profile |
Other Information on Investing in Teyi Stock
Teyi Pharmaceutical financial ratios help investors to determine whether Teyi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Teyi with respect to the benefits of owning Teyi Pharmaceutical security.